Mark Boyd

4.5k total citations · 1 hit paper
145 papers, 2.8k citations indexed

About

Mark Boyd is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Mark Boyd has authored 145 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Infectious Diseases, 56 papers in Virology and 21 papers in Emergency Medicine. Recurrent topics in Mark Boyd's work include HIV/AIDS drug development and treatment (59 papers), HIV Research and Treatment (56 papers) and HIV/AIDS Research and Interventions (53 papers). Mark Boyd is often cited by papers focused on HIV/AIDS drug development and treatment (59 papers), HIV Research and Treatment (56 papers) and HIV/AIDS Research and Interventions (53 papers). Mark Boyd collaborates with scholars based in Australia, United States and Thailand. Mark Boyd's co-authors include J.B. Dugan, Salvatore J. Bavuso, David A. Cooper, Kiat Ruxrungtham, Praphan Phanuphak, Sean Emery, Janaki Amin, Apicha Mahanontharit, Kathy Petoumenos and Joep MA Lange and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mark Boyd

132 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dynamic fault-tree models for fault-tolerant computer systems

1992 525 citations J.B. Dugan, Salvatore J. Bavuso et al. IEEE Transactions on Reliability profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Boyd Australia	26	1.3k	875	540	471	447	145	2.8k
Victor DeGruttola United States	32	1.9k 1.5×	1.6k 1.9×	686 1.3×	7 0.0×	460 1.0×	100	3.4k
Craig B. Borkowf United States	25	1.3k 1.0×	375 0.4×	853 1.6×	3 0.0×	188 0.4×	63	3.1k
A. Amendola Italy	25	419 0.3×	95 0.1×	988 1.8×	35 0.1×	6 0.0×	126	2.3k
Rodger D. MacArthur United States	30	1.9k 1.4×	1.5k 1.7×	1.0k 1.9×	4 0.0×	518 1.2×	81	3.7k
Eva K. Lee United States	28	777 0.6×	209 0.2×	940 1.7×	5 0.0×	143 0.3×	90	3.8k
Stefano Conti United Kingdom	19	299 0.2×	50 0.1×	298 0.6×	5 0.0×	28 0.1×	35	1.3k
Steve Bennett United Kingdom	25	888 0.7×	40 0.0×	615 1.1×	4 0.0×	18 0.0×	41	2.7k
Jennifer M. Anderson United States	42	719 0.5×	45 0.1×	440 0.8×	110 0.2×	93 0.2×	114	5.7k
William J. Long United States	31	276 0.2×	247 0.3×	232 0.4×	10 0.0×	46 0.1×	215	3.6k

Countries citing papers authored by Mark Boyd

Since Specialization

Citations

This map shows the geographic impact of Mark Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Boyd more than expected).

Fields of papers citing papers by Mark Boyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Boyd. The network helps show where Mark Boyd may publish in the future.

Co-authorship network of co-authors of Mark Boyd

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Boyd. A scholar is included among the top collaborators of Mark Boyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Boyd. Mark Boyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stretton, Brandon, Joshua G. Kovoor, Aashray Gupta, et al.. (2024). Chronic glycemic control influences the relationship between acute perioperative dysglycemia and perioperative outcome. Journal of Diabetes. 16(10). e70015–e70015. 1 indexed citations

Stretton, Brandon, Joshua G. Kovoor, Aashray Gupta, et al.. (2024). Impact of frailty, malnutrition and socioeconomic status on perioperative outcomes. Age and Ageing. 53(12). 4 indexed citations

Stretton, Brandon, Joshua G. Kovoor, Stephen Bacchi, et al.. (2023). Impact of perioperative direct oral anticoagulant assays: a multicenter cohort study. Hospital Practice. 51(3). 155–162. 5 indexed citations

Stretton, Brandon, Joshua G. Kovoor, Aashray Gupta, et al.. (2023). Get out what you put in: optimising electronic medical record data. ANZ Journal of Surgery. 93(9). 2056–2058. 5 indexed citations

Karran, Emma L., Aidan G Cashin, Trevor Barker, et al.. (2023). Using PROGRESS-plus to identify current approaches to the collection and reporting of equity-relevant data: a scoping review. Journal of Clinical Epidemiology. 163. 70–78. 24 indexed citations

Karran, Emma L., Aidan G Cashin, Trevor Barker, et al.. (2023). Development of recommendations for a minimum dataset for Identifying Social factors that Stratify Health Opportunities and Outcomes (ISSHOOs) in pain research. MethodsX. 12. 102496–102496. 4 indexed citations

Zaunders, John, Michelle Bailey, Nabila Seddiki, et al.. (2021). Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection. Frontiers in Immunology. 12. 688886–688886. 12 indexed citations

Aung, Ne Myo, et al.. (2021). The impact of gender and the social determinants of health on the clinical course of people living with HIV in Myanmar: an observational study. AIDS Research and Therapy. 18(1). 50–50. 4 indexed citations

Aung, Ne Myo, Zaw Win Htet, Mark Boyd, et al.. (2017). The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study. BMC Medicine. 15(1). 145–145. 21 indexed citations

10.

Zaunders, John, Mark Danta, Michelle Bailey, et al.. (2016). CD4+ T Follicular Helper and IgA+ B Cell Numbers in Gut Biopsies from HIV-Infected Subjects on Antiretroviral Therapy Are Similar to HIV-Uninfected Individuals. Frontiers in Immunology. 7. 438–438. 12 indexed citations

11.

Moore, Cecilia L., Eduardo Gotuzzo, Adeeba Kamarulzaman, et al.. (2016). Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study. AIDS Research and Human Retroviruses. 32(9). 841–850. 12 indexed citations

12.

Amin, Janaki, Mark Boyd, Nagalingeswaran Kumarasamy, et al.. (2015). Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection. PLoS ONE. 10(2). e0118228–e0118228. 31 indexed citations

13.

Avihingsanon, Anchalee, Jasper van der Lugt, Mark Boyd, et al.. (2012). Pharmacokinetics and 48 Week Efficacy of Adjusted Dose Indinavir/Ritonavir in Rifampicin-Treated HIV/Tuberculosis-Coinfected Patients: A Pilot Study. AIDS Research and Human Retroviruses. 28(10). 1170–1176. 5 indexed citations

14.

Byakwaga, Helen, John M. Murray, Kathy Petoumenos, et al.. (2009). Evolution of CD4 ⁺ T Cell Count in HIV-1-Infected Adults Receiving Antiretroviral Therapy with Sustained Long-Term Virological Suppression. AIDS Research and Human Retroviruses. 25(6). 569–576. 8 indexed citations

15.

Boyd, Mark, et al.. (2008). A Randomized Study to Evaluate Injection Site Reactions using Three Different Enfuvirtide Delivery Mechanisms (the OPTIONS Study). Antiviral Therapy. 13(3). 449–454. 11 indexed citations

16.

Boyd, Mark & David A. Cooper. (2007). Second-line combination antiretroviral therapy in resource-limited settings: facing the challenges through clinical research. AIDS. 21(Suppl 4). S55–S63. 48 indexed citations

17.

Boyd, Mark. (2006). The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicity. Journal of Antimicrobial Chemotherapy. 57(6). 1161–1167. 18 indexed citations

18.

Boyd, Mark, Preeyaporn Srasuebkul, Kiat Ruxrungtham, et al.. (2006). Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir. Pharmacogenetics and Genomics. 16(5). 321–329. 43 indexed citations

19.

Boyd, Mark, et al.. (1998). An Introduction to Markov Modeling: Concepts and Uses. NASA STI Repository (National Aeronautics and Space Administration). 6 indexed citations

20.

Dugan, J.B., Salvatore J. Bavuso, & Mark Boyd. (1992). Dynamic fault-tree models for fault-tolerant computer systems. IEEE Transactions on Reliability. 41(3). 363–377. 525 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact